With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022 | Fierce Pharma
Bortezomib 26-S 3.5mg sol iny - Solmedix
RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 1. DENOMINAZIONE DEL MEDICINALE Bortezomib Teva 2,5 mg polvere per soluzione iniett
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma | Blood Cancer Journal
View of Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored at 4°C and Room Temperature (23°C or 25°C) | Canadian Journal of Hospital Pharmacy
Bortezomib prašak za injekciju (3,5 mg) – Uputa o lijeku